These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26444860)

  • 1. Molecular network of important genes for systemic sclerosis-related progressive lung fibrosis.
    Jiao Y; Chen H; Gu T; Wang L; Postlethwaite A; Gu W
    BMC Res Notes; 2015 Oct; 8():544. PubMed ID: 26444860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.
    Christmann RB; Sampaio-Barros P; Stifano G; Borges CL; de Carvalho CR; Kairalla R; Parra ER; Spira A; Simms R; Capellozzi VL; Lafyatis R
    Arthritis Rheumatol; 2014 Mar; 66(3):714-25. PubMed ID: 24574232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis.
    Tyler A; Mahoney JM; Carter GW
    G3 (Bethesda); 2020 Jan; 10(1):151-163. PubMed ID: 31694854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.
    Sargent JL; Li Z; Aliprantis AO; Greenblatt M; Lemaire R; Wu MH; Wei J; Taroni J; Harris A; Long KB; Burgwin C; Artlett CM; Blankenhorn EP; Lafyatis R; Varga J; Clark SH; Whitfield ML
    Arthritis Rheumatol; 2016 Aug; 68(8):2003-15. PubMed ID: 26945694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers.
    Landi C; Bargagli E; Carleo A; Refini RM; Bennett D; Bianchi L; Cillis G; Prasse A; Bini L; Rottoli P
    Rheumatology (Oxford); 2019 Jan; 58(1):165-178. PubMed ID: 30239835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms.
    Doskaliuk B; Zaiats L; Yatsyshyn R; Gerych P; Cherniuk N; Zimba O
    Rheumatol Int; 2020 Oct; 40(10):1555-1569. PubMed ID: 32715342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients.
    Luzina IG; Atamas SP; Wise R; Wigley FM; Choi J; Xiao HQ; White B
    Arthritis Rheum; 2003 Aug; 48(8):2262-74. PubMed ID: 12905481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulator combinations identify systemic sclerosis patients with more severe disease.
    Wang Y; Franks JM; Yang M; Toledo DM; Wood TA; Hinchcliff M; Whitfield ML
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32721949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis.
    Avila JJ; Lympany PA; Pantelidis P; Welsh KI; Black CM; du Bois RM
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):106-12. PubMed ID: 9870923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis.
    Mehta H; Goulet PO; Mashiko S; Desjardins J; Pérez G; Koenig M; Senécal JL; Constante M; Santos MM; Sarfati M
    J Invest Dermatol; 2017 Nov; 137(11):2316-2325. PubMed ID: 28757138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
    Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J
    J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.
    Mallano T; Palumbo-Zerr K; Zerr P; Ramming A; Zeller B; Beyer C; Dees C; Huang J; Hai T; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Mar; 75(3):586-92. PubMed ID: 25589515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.